3-iodobenzylguanidine has been researched along with Supranuclear Palsy, Progressive in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 8 (72.73) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Homma, T; Takubo, H; Uchihara, T; Yoshimura, N | 1 |
| Hoshino, T; Irie, KI; Kamada, T; Kida, H; Miura, S; Taniwaki, T; Yamanishi, Y | 1 |
| Dillmann, U; Dogan, S; Ezziddin, S; Fassbender, K; Schaefer-Schuler, A; Schubert, E; Spiegel, J | 1 |
| Abe, K; Hatanaka, N; Hishikawa, N; Matsuzono, K; Ohta, Y; Sato, K; Takamatsu, K; Takemi, T; Takemoto, M; Tsunoda, K; Yamashita, T | 1 |
| Hirata, K; Iwanami, M; Miyamoto, M; Miyamoto, T; Nishibayashi, M; Suzuki, K | 1 |
| Berganzo, K; Gómez-Esteban, JC; Iodice, V; Lezcano, E; Llorens, V; Low, D; Mathias, CJ; Sánchez-Manso, JC; Somme, JH; Tijero, B; Vichayanrat, E; Zarranz, JJ | 1 |
| Abe, K; Deguchi, K; Deguchi, S; Ikeda, Y; Kametaka, S; Kurata, T; Manabe, Y; Morimoto, N; Ohta, T; Ohta, Y; Sato, S; Takao, Y | 1 |
| Kasahata, N; Makita, Y; Nakamura, A; Orimo, S; Uchihara, T | 1 |
| Adachi, T; Kitayama, M; Nakano, T; Nakashima, K; Wada-Isoe, K | 1 |
| Hayashi, M; Hirai, S; Yoshita, M | 1 |
| Yoshita, M | 1 |
1 trial(s) available for 3-iodobenzylguanidine and Supranuclear Palsy, Progressive
| Article | Year |
|---|---|
[Iodine 123-labeled meta-iodobenzylguanidine myocardial scintigraphy in the cases of idiopathic Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy].
Topics: 3-Iodobenzylguanidine; Aged; Diagnosis, Differential; Female; Heart; Humans; Iodine Radioisotopes; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Supranuclear Palsy, Progressive; Sympathetic Nervous System | 1997 |
10 other study(ies) available for 3-iodobenzylguanidine and Supranuclear Palsy, Progressive
| Article | Year |
|---|---|
[Decreased Uptake of Metaiodobenzylguanidine (MIBG) Myocardial Scintigraphy in a 64-year-old Female, Who Was Diagnosed as a Progressive Supranuclear Palsy].
Topics: 3-Iodobenzylguanidine; Female; Humans; Middle Aged; Myocardial Perfusion Imaging; Radiopharmaceuticals; Supranuclear Palsy, Progressive | 2018 |
MIBG myocardial scintigraphy in progressive supranuclear palsy.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Atrophy; Brain Stem; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple System Atrophy; Myocardial Perfusion Imaging; Parkinson Disease; Radiopharmaceuticals; Retrospective Studies; Supranuclear Palsy, Progressive | 2019 |
MIBG scintigraphy of the major salivary glands in progressive supranuclear palsy and corticobasal degeneration.
Topics: 3-Iodobenzylguanidine; Aged; Basal Ganglia Diseases; Female; Humans; Male; Middle Aged; Parotid Gland; Radionuclide Imaging; Radiopharmaceuticals; Submandibular Gland; Supranuclear Palsy, Progressive | 2019 |
Potential multisystem degeneration in Asidan patients.
Topics: 3-Iodobenzylguanidine; Aged; Brain; Family; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Perfusion Imaging; Parkinson Disease; Pedigree; Radiopharmaceuticals; Spinocerebellar Degenerations; Supranuclear Palsy, Progressive; Tomography, Emission-Computed, Single-Photon; Tropanes | 2017 |
123I-MIBG cardiac scintigraphy provides clues to the underlying neurodegenerative disorder in idiopathic REM sleep behavior disorder.
Topics: 3-Iodobenzylguanidine; Aged; Cross-Sectional Studies; Diagnosis, Differential; Female; Heart; Humans; Lewy Body Disease; Male; Mediastinum; Middle Aged; Multiple System Atrophy; Neurodegenerative Diseases; Parkinson Disease; Polysomnography; Radionuclide Imaging; REM Sleep Behavior Disorder; Supranuclear Palsy, Progressive | 2008 |
SCOPA-AUT scale in different parkinsonisms and its correlation with (123) I-MIBG cardiac scintigraphy.
Topics: 3-Iodobenzylguanidine; Aged; Diagnosis, Differential; Female; Heart; Humans; Male; Mediastinum; Middle Aged; Multiple System Atrophy; Parkinson Disease; Parkinsonian Disorders; Severity of Illness Index; Supranuclear Palsy, Progressive; Tomography, Emission-Computed, Single-Photon | 2012 |
PSP as distinguished from CBD, MSA-P and PD by clinical and imaging differences at an early stage.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Basal Ganglia; Cerebral Cortex; Cerebrovascular Circulation; Cysteine; Diagnosis, Differential; Female; Humans; Male; Middle Aged; Multiple System Atrophy; Neurodegenerative Diseases; Organotechnetium Compounds; Parkinson Disease; Parkinsonian Disorders; Radiopharmaceuticals; Supranuclear Palsy, Progressive; Tomography, Emission-Computed, Single-Photon | 2011 |
Limbic and nigral Lewy bodies and Alzheimer's disease pathology mimicking progressive supranuclear palsy in a 75-year-old man with preserved cardiac uptake of MIBG.
Topics: 3-Iodobenzylguanidine; Aged; Alzheimer Disease; Diagnosis, Differential; Humans; Lewy Bodies; Limbic System; Magnetic Resonance Imaging; Male; Myocardium; Substantia Nigra; Supranuclear Palsy, Progressive | 2012 |
Autopsy-confirmed progressive supranuclear palsy with decreased uptake of metaiodobenzylguanidine.
Topics: 3-Iodobenzylguanidine; Aged; Autopsy; Brain; Gliosis; Humans; Male; Neurons; Pneumonia; Radionuclide Imaging; Radiopharmaceuticals; Supranuclear Palsy, Progressive; Tegmentum Mesencephali | 2013 |
Differentiation of idiopathic Parkinson's disease from striatonigral degeneration and progressive supranuclear palsy using iodine-123 meta-iodobenzylguanidine myocardial scintigraphy.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Radionuclide Imaging; Supranuclear Palsy, Progressive | 1998 |